Regulatory Actions

Chawla MD, 3/10

Date Published:
Wed, 03/17/2010

Warning letter citing delayed entry of adverse event data into the eCRF.

3CPM company, 3/10

Date Published:
Thu, 03/25/2010

Warning Letter citing multiple validation and change control issues for both product and quality systems.

Oympus Temmo Biomaterials, 2/10

Date Published:
Thu, 02/25/2010

Warning Letter citation referring to failure to validate CAPA analysis software

Interacoustics A/S, 12/09

Date Published:
Thu, 12/10/2009

Failure to validate software changes prior to implementation

Ohm Laboratories, 8/09

Date Published:
Wed, 08/12/2009

483 identifying multiple deficiencies in security, back-ups, and password protection for laboratory systems.

Toledo MD, 3/10

Date Published:
Thu, 03/11/2010

Warning letter highlighting multiple discrepancies between source documents and electronic records.

Cardiac Science, 2/10

Date Published:
Fri, 02/05/2010

Warning Letter citation highlighting multiple CAPA and validation issues for device software.

Xian Libang Pharmaceutical, 1/10

Date Published:
Thu, 01/28/2010

Warning Letter requesting details of the configuration, qualification approach, and procedures for a system referenced in an earlier audit response.

Ohm Laboratories, 12/09

Date Published:
Mon, 12/21/2009

Warning Letter highlighting several issues potentially impacting the integrity of laboratory data.

Crothal Healthcare, 12/09

Warning Letter noting that company did not provide evidence of system validation or usage procedures.

Syndicate content